Article
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression.
Molecular psychiatry - 1 Jul 2010
Kloiber S, Kohli M A, Brueckl T, Ripke S, Ising M, Uhr M, Menke A, Unschuld P G, Horstmann S, Salyakina D, Muller-Myhsok B, Binder E B, Holsboer F, Lucae S
Abstract excerpt
Major depression and the metabolic syndrome (MetS) are interacting clinical conditions influenced by genetic susceptibility. For both disorders, impaired serotonergic neurotransmission in specific brain areas has been suggested. This led us to investigate whether variants in the gene coding for tryptophan hydroxylase 2 (TPH2), the brain-specific and rate-limiting enzyme for serotonin biosynthesis, might be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
